Nuclivision
Latest round
- Seed
Last raised
- May 2025
Total raised
- $2.3M
Investors
- 3
About Nuclivision
Founded in 2022 in Ghent, Belgium, Nuclivision BV focuses on developing specialized software solutions for the nuclear medicine field. The company recently pivoted its operations to concentrate on artificial intelligence applications in PET imaging. With only 1 total deal reported, their most recent deal occurred on April 24, 2025.Nuclivision specializes in advanced software solutions for the nuclear medicine field, focusing on enhancing the workflow of physicians from image acquisition to diagnosis and follow-up. Their flagship product, Nuclarity, utilizes artificial intelligence to improve the quality of PET imaging, which is critical in oncologic and neurologic diagnoses, thereby reducing patient wait times for scans and treatment. The solutions are designed to optimize processes within imaging centers, ensuring that patient safety is prioritized by minimizing radiation exposure during scans.Nuclivision generates revenue primarily through a subscription-based model for its software products, particularly Nuclarity. Healthcare providers and imaging centers enter into service agreements that include both upfront software installation fees and ongoing subscription payments for software updates and support. This model allows clients to access the latest advancements in imaging technology while ensuring continuous service and maintenance. The revenue structure also incorporates potential partnerships with healthcare organizations for collaborative usage of its technologies, enhancing diagnostic capabilities. Upcoming products and enhancements are aimed at further improving their imaging solutions, with specific market entry strategies being developed for targeted regions. Further details on specific upcoming products and additional geographic markets are anticipated to be announced in conjunction with the rollout.
Who invested in Nuclivision
3 investors across 1 round
See all investors in Nuclivision
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
May 7, 2025
Amount
$2.3M
Investors
Questions about Nuclivision
Who invested in Nuclivision?
Nuclivision has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Nuclivision raised?
Nuclivision has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Nuclivision last raise money?
Nuclivision's most recent round on record is a Seed, in May 2025.
What does Nuclivision do?
Founded in 2022 in Ghent, Belgium, Nuclivision BV focuses on developing specialized software solutions for the nuclear medicine field.
Where is Nuclivision headquartered?
Nuclivision is headquartered in Ghent, Belgium.
Which VCs invest in companies like Nuclivision?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back medical devices & equipment companies at Nuclivision's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Seed
Raising like Nuclivision? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.